Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19221336 | 0.92 | PDE4A (0.31) | — | |
| SCHEMBL6996440 | 0.67 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL2935553 | 0.67 | — | — | |
| SCHEMBL7118968 | 0.64 | ATM (0.36) | CYP1A2 | |
| SCHEMBL12680648 | 0.63 | ATM (0.33) | CYP1A2MEN1KMT2A | |
| SCHEMBL16181410 | 0.60 | HTT (0.42) | CYP1A2MEN1MAPTKMT2A | |
| SCHEMBL16975489 | 0.53 | CYP1A2 (0.39) | CYP1A2MAPT | |
| SCHEMBL2652285 | 0.53 | — | — | |
| SCHEMBL2647730 | 0.53 | POLB (0.34) | — | |
| SCHEMBL2935690 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10774171-B2 | Energetic compounds and compositions | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2020-09-15 | — | — | US | disclosed |
| EP-3212635-B1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECH INNOVATION MOMENTUM FUND ISREAL LIMITED PARTNERSHIP (IL) | 2020-04-22 | — | — | EP | disclosed |
| US-20190092895-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2019-03-28 | — | — | US | disclosed |
| US-10196477-B2 | Energetic compounds and compositions | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2019-02-05 | — | — | US | disclosed |
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-10 | — | — | US | disclosed |
| WO-2016067292-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2016-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190092895-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | CYP1A2 1535/4885MEN1 1701/4885MAPT 2137/4885 |
| US-10196477-B2 | Energetic compounds and compositions | GNA11, THEM6, TXN2 | CYP1A2 1502/4885MEN1 1755/4885MAPT 2185/4885 |
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | CYP1A2 1502/4885MEN1 1755/4885MAPT 2185/4885 |
| US-10774171-B2 | Energetic compounds and compositions | GNA11, THEM6, TXN2 | CYP1A2 1535/4885MEN1 1701/4885MAPT 2137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.